GS
JAZZ icon

George Soros’s Jazz Pharmaceuticals JAZZ Stock Holding History

George Soros’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,800
Closed -$1.1M – 251
2016
Q2 		$1.1M Buy
+7,800
New +$1.15M 0.02% 126
2016
Q1 		– Sell
-3,200
Closed -$450K – 269
2015
Q4 		$450K Buy
+3,200
New +$443K 0.01% 198
2014
Q2 		– Sell
-3,600
Closed -$499K – 406
2014
Q1 		$499K Buy
+3,600
New +$542K ﹤0.01% 269

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

George Soros's JAZZ Position: Q3 2016 in Review

George Soros sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 7,800 shares — an estimated $1.1M sold.

George Soros first reported a position in JAZZ in Q1 2014 and held it in 3 quarters. The position peaked at $1.1M in Q2 2016. 326 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

  • George Soros reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • George Soros sold 7,800 Jazz Pharmaceuticals shares in Q3 2016, an estimated $1.1M.
  • George Soros first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • George Soros's Jazz Pharmaceuticals position peaked at $1.1M in Q2 2016.
  • 326 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Soros Fund Management's 13F filing for Q3 2016, filed 14 Nov 2016.